MIIT: Accelerating Formulation of Documents to Cultivate a National Integrated Technology Market, Breaking Down Transaction Barriers and Institutional Obstacles 工信部：正在加紧制定培育全国一体化技术市场相关文件，破除交易壁垒和制度障碍

Summary

The Ministry of Industry and Information Technology (MIIT) is accelerating the formulation of policy documents to cultivate a unified national technology market, aiming to dismantle regional barriers and institutional obstacles while establishing a national unified technology trading service platform.
It aims to establish full-chain service capabilities spanning from research and development (R&D) to pilot testing and incubation, and to expedite the formulation of reform measures and standards to strengthen the construction of a team of technology managers.
In the first half of the year, the innovation capacity of the pharmaceutical industry significantly strengthened, with 38 innovative drugs approved for market launch, over 80% of which were domestically produced. The transaction volume for external technology licensing exceeded $100 billion.

Deep Analysis

TL;DR

• The MIIT is accelerating the formulation of policy documents to cultivate a unified national technology market, aiming to dismantle regional barriers and institutional obstacles while establishing a national unified technology trading service platform.
• It aims to establish full-chain service capabilities spanning from R&D to pilot testing and incubation, and to expedite the formulation of reform measures and standards to strengthen the construction of a team of technology managers.
• In the first half of the year, the innovation capacity of the pharmaceutical industry significantly strengthened, with 38 innovative drugs approved for market launch, over 80% of which were domestically produced. The transaction volume for external technology licensing exceeded $100 billion.

Why It’s Worth Reading

This article reveals major policy trends at the national level in promoting the market-oriented allocation of technological factors, offering direct guidance for practitioners concerned with the transformation of scientific and technological achievements, technology brokerage services, and related infrastructure construction. Meanwhile, the substantial data on pharmaceutical technology licensing transactions confirms the growing capacity of China’s hard-tech sector to go global, providing key macroeconomic indicators for assessing industrial innovation quality.

Technical Analysis

• Construction of a Unified National Technology Market: The core initiative is to build a "National Unified Technology Trading Service Platform," using digital means to break geographical limitations and address the issue where high-quality technologies struggle to access the national market due to channel constraints, thereby facilitating the free flow of technological factors.
• Full-Chain Incubation System: Establishes full-chain service capabilities covering "R&D – Pilot Testing – Incubation," emphasizing that beyond generating R&D outputs, there must be strengthened emphasis on pilot testing verification and industrialization incubation to improve the conversion rate and survival rate of scientific and technological achievements.
• Institutionalization of Technology Managers: Proposes a model of "industry posing questions, science and technology answering them." By leveraging the role of technology managers (intermediaries facilitating matches), it aims to clear bottlenecks between research outputs and practical application. Relevant policy standards and reform measures for team building are imminent.
• Quantitative Indicators of Pharmaceutical Innovation: Data shows that 38 innovative drugs were approved in the first half of the year (with domestic products accounting for >80%), including a batch of "first-in-the-world" results. Total external technology licensing exceeded $100 billion, reflecting a systematic leap from following innovation to source innovation.

Industry Implications

• Policy Dividends for Technology Brokerage and Intermediary Services: With the establishment of a national unified trading platform and standards for technology managers, professional technology transfer agencies, consulting service platforms, and technology brokers with deep industry insights will gain greater market space and opportunities for standardized development.
• Hard-Tech Global Expansion and Licensing Models as New Growth Drivers: The trillion-dollar-level licensing transactions in the pharmaceutical sector indicate that Chinese tech enterprises are shifting from simple product exports to exporting high-value-added intellectual property and technology licenses. Other hard-tech sectors may follow this trend.
• Focus on Investment in Pilot Testing and Industrialization Infrastructure: The policy’s emphasis on the "full chain," particularly the pilot testing phase, implies that investment and construction in industrialization infrastructure such as pilot testing bases, shared laboratories, and proof-of-concept centers will become key directions supported by policy and capital attention.

TL;DR

• 工信部正加紧制定培育全国一体化技术市场的政策文件，旨在破除区域壁垒和制度障碍，建设国家统一技术交易服务平台。
• 建立从研发到中试再到孵化的全链条服务能力，并加快制定加强技术经理人队伍建设的改革举措及标准。
• 上半年医药工业创新能力显著增强，38款创新药获批上市其中国产占80%以上，对外技术授权交易额超1000亿美元。

为什么值得看

本文揭示了国家层面推动技术要素市场化配置的重大政策动向，对于关注科技成果转化、技术经纪服务及相关基础设施建设的从业者具有直接指导意义。同时，医药工业的高额授权交易数据印证了中国硬科技出海能力的提升，为判断产业创新质量提供了关键宏观指标。

技术解析

• 全国一体化技术市场建设：核心举措是建设“国家统一技术交易服务平台”，通过数字化手段打破地域限制，解决优质技术因渠道受限难以对接全国市场的问题，促进技术要素自由流动。
• 全链条孵化体系：构建了“研发-中试-孵化”的全链条服务能力，强调不仅要有研发产出，更要强化中试验证和产业化孵化环节，提高科技成果的转化率和存活率。
• 技术经理人制度化：提出“产业出题、科技答题”的模式，通过发挥技术经理人（中介撮合）的作用，打通科研产出与应用落地的堵点，相关政策标准和队伍建设改革措施即将出台。
• 医药创新量化指标：数据显示上半年38款创新药获批（国产占比>80%），且出现一批“全球首个”成果，对外技术授权总额突破1000亿美元，体现了从跟随创新向源头创新的系统性跃升。

行业启示

• 技术经纪与中介服务迎来政策红利：随着国家统一交易平台和技术经理人标准的建立，专业的技术转移机构、咨询服务平台及具备产业理解力的技术经纪人将获得更大的市场空间和规范化发展机遇。
• 硬科技出海与授权模式成为新增长点：医药领域千亿美元级的授权交易表明，中国科技企业正从单纯的产品出口转向高附加值的知识产权和技术授权输出，其他硬科技领域可能跟进这一趋势。
• 关注中试与产业化基础设施投资：政策强调“全链条”特别是中试环节，意味着针对中试基地、共享实验室、概念验证中心等产业化基础设施的投资和建设将成为政策支持和资本关注的重点方向。